Edition:
United Kingdom

Medigene AG (MDG1k.DE)

MDG1k.DE on Xetra

8.20EUR
9:28am BST
Change (% chg)

€-0.12 (-1.38%)
Prev Close
€8.32
Open
€8.37
Day's High
€8.37
Day's Low
€8.15
Volume
17,557
Avg. Vol
89,260
52-wk High
€16.05
52-wk Low
€7.20

About

Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modi... (more)

Overall

Beta: 1.61
Market Cap(Mil.): €204.34
Shares Outstanding(Mil.): 24.56
Dividend: --
Yield (%): --

Financials

  MDG1k.DE Industry Sector
P/E (TTM): -- 93.91 35.38
EPS (TTM): -0.72 -- --
ROI: -15.18 7.62 11.72
ROE: -16.97 8.12 16.38

Earnings vs. Estimates